目的:探讨腹膜透析相关性腹膜炎的治疗。方法:回顾性分析的89例腹膜透析相关性腹膜炎患者,初期使用头孢菌素和或氨基糖甙类抗生素治疗,严重者使用头孢唑林和头孢他啶治疗。结果:89例腹膜炎患者透析液培养阳性33例(37.1%),其中19例1~4d治愈(21.3%),56例4~14 d治愈(62.9%),复发11例(12.4%),2例因尿毒症而全身衰竭死亡(2.2%)。结论:虽然腹膜透析相关性腹膜炎的发病率有降低趋势,但其仍然是腹膜透析最常见并发症之一,我们在强调对腹膜炎治疗的同时,更要强调对腹膜炎的预防。
Citation:
TANG Yong,HU Qing. Treatment for Peritoneal Dialysis-Associated Peritonitis. West China Medical Journal, 2009, 24(7): 1755-1757. doi:
Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
1. |
PIRAINO B, BAILIE G R, BERNARDINI J, et al. Peritoneal dialysisrelated infections recommendations:2005 update.[J]. Perit Dial Int,2005,25(2):107-131.
|
2. |
FRIED L F, BERNARDINI J, JOHNSTON J R, et al. Peritonitis influences mortality in peritoneal dialysis patients.[J]. J Am Soc Nephrol,1996,7(10):2176-2182.
|
3. |
董捷. 关于2005年ISPD腹膜透析相关感染诊治指南的几点思考[J]. 中国血液净化,2008,(03):117-119.
|
4. |
郭群英, 陈林, 阳晓, 等. 腹膜透析相关感染性腹膜炎致病菌及菌谱变化-单个腹膜透析中心15年回顾分析[J]. 中华肾脏病杂志,2006,(12):719-724.
|
5. |
MIGUEL A, GARCIARAMON R, PEREZCONTRERAS J, et al. Comorbidity and mortality in peritoneal dialysis:a comparative study of type 1 and 2 diabetes versus nondiabetic patients. Peritoneal dialysis and diabetes.[J]. Nephron,2002,90(3):290-296.
|
6. |
黎伟, 廖蕴华, 薛超, 等. 腹膜透析相关性腹膜炎相关因素分析[J]. 广东医学,2007,(08):1292-1294.
|
7. |
VENMANS L M, SLOOF M, HAK E, et al. Prediction of complicated urinary tract infections in patients with type 2 diabetes:a questionnaire study in primary care.[J]. Eur J Epidemiol,2007,22(1):49-54.
|
8. |
GOLPER T A, BRIER M E, BUNKE M, et al. Risk factors for peritonitis in longterm peritoneal dialysis:the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies.[J]. Am J Kidney Dis,1996,28(3):428-436.
|
9. |
SZETO C C, CHOW K M, KWAN B C, et al. Staphylococcus aureus peritonitis complicates peritoneal dialysis:review of 245 consecutive cases.[J]. Clin J Am Soc Nephrol,2007,2(2):245-251.
|
10. |
林爱武. 腹膜透析患者腹膜炎的监测和预防[J]. 肾脏病与透析肾移植杂志,2008,(06):537-538.
|
- 1. PIRAINO B, BAILIE G R, BERNARDINI J, et al. Peritoneal dialysisrelated infections recommendations:2005 update.[J]. Perit Dial Int,2005,25(2):107-131.
- 2. FRIED L F, BERNARDINI J, JOHNSTON J R, et al. Peritonitis influences mortality in peritoneal dialysis patients.[J]. J Am Soc Nephrol,1996,7(10):2176-2182.
- 3. 董捷. 关于2005年ISPD腹膜透析相关感染诊治指南的几点思考[J]. 中国血液净化,2008,(03):117-119.
- 4. 郭群英, 陈林, 阳晓, 等. 腹膜透析相关感染性腹膜炎致病菌及菌谱变化-单个腹膜透析中心15年回顾分析[J]. 中华肾脏病杂志,2006,(12):719-724.
- 5. MIGUEL A, GARCIARAMON R, PEREZCONTRERAS J, et al. Comorbidity and mortality in peritoneal dialysis:a comparative study of type 1 and 2 diabetes versus nondiabetic patients. Peritoneal dialysis and diabetes.[J]. Nephron,2002,90(3):290-296.
- 6. 黎伟, 廖蕴华, 薛超, 等. 腹膜透析相关性腹膜炎相关因素分析[J]. 广东医学,2007,(08):1292-1294.
- 7. VENMANS L M, SLOOF M, HAK E, et al. Prediction of complicated urinary tract infections in patients with type 2 diabetes:a questionnaire study in primary care.[J]. Eur J Epidemiol,2007,22(1):49-54.
- 8. GOLPER T A, BRIER M E, BUNKE M, et al. Risk factors for peritonitis in longterm peritoneal dialysis:the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies.[J]. Am J Kidney Dis,1996,28(3):428-436.
- 9. SZETO C C, CHOW K M, KWAN B C, et al. Staphylococcus aureus peritonitis complicates peritoneal dialysis:review of 245 consecutive cases.[J]. Clin J Am Soc Nephrol,2007,2(2):245-251.
- 10. 林爱武. 腹膜透析患者腹膜炎的监测和预防[J]. 肾脏病与透析肾移植杂志,2008,(06):537-538.